Lindus Health’s Post

ePRO collects a wide array of data valuable to #consumerhealth trials, including user satisfaction and experience, compliance, quality of life, and much more. This method of data capture streamlines #clinicaloperations in these studies in various ways, as discussed in our latest blog. Read the full blog here: https://lnkd.in/e-hD_M8J #ePRO #consumerhealth #clinicaltrials #datamanagement

This week, the FDA advisory committee rejected the validation of therapy-assisted #MDMA clinical trials in treating #PTSD. The psychedelic research community has a lot to say about their jurisdiction, including Lindus Health advisor Acacia Parks. Read the full article in Clinical Leader here: https://lnkd.in/eQZRGiNj #psychedelicresearch #clinicaltrials #drugdevelopment #regulatory

Consumer health trials offer more flexibility than traditional trials and should operate with a patient-first mentality. Our newest guide offers strategies to cultivate just that, along with other helpful considerations for design and recruitment for the unique nature of these studies. Get the guide here: https://lnkd.in/en8vXCSZ #consumerhealth #patientretention #recruitment #clinicaltrials

GLP-1 medications are highly effective in treating type 2 diabetes and obesity, producing significant benefits in glycemic control, weight loss, cardiovascular risk factors, and overall quality of life. However, despite their marked success, they still face hesitation for adoption in the #primarycare setting. Co-written with our advisor Dr. Carel Le Roux, involved in the SURMOUNT-2 clinical trial that evaluated #tirzepatide on weight reduction maintenance, our latest blog covers trial design considerations for the successful execution of #GLP1 medication studies involving primary care sites. Read the full blog here: https://lnkd.in/eiEE4GkC #diabetes #obesity #weightmanagement #metabolichealth #clinicaltrials

This Friday, co-founder Michael Young will be participating in a panel discussion at Nucleate UK’s invite-only event, The Forum. He will be joined by Molly Stevens of University of Oxford and Benedict Macon-Cooney of the Tony Blair Institute for Global Change to discuss the direction of commercializing the UK’s science ecosystem. Be sure to check out our panel and say hi to Michael Young if you’re attending! #biotech #healthcareinnovation #startup #pharma

We’re thrilled to announce our collaboration with Tasso, Inc. - the leading provider of patient-centric, clinical grade blood collection solutions! Lindus Health will be incorporating Tasso's virtually painless remote blood collection technology, offering it as an option for sponsors who want to facilitate easy and cost-effective remote blood sampling during their clinical trials. The adoption of their cutting-edge technology allows us to enhance our efforts of cultivating exceptional clinical trial experiences to not only sponsors, but study participants as well. Read the release here: https://lnkd.in/eq_QPBgu #clinicaltrials #patientexperience #samplecollection

In just a few days, co-founder Meri Beckwith will be joining Leo Benning of Vivira Health Lab and Magdalena Plotczyk, PhD of MTIP at health.tech conference! If you’re there, you won’t want to miss our panel discussion where we’ll discuss how innovative #digitalhealth technologies are transforming cardiac disease management. Hope to see you in Munich! #cardiovascular #digitalhealth #clinicalresearch

In Vator's latest podcast episode, co-founder Meri Beckwith sat down to discuss his journey in starting Lindus Health, our novel business model and how we strive to improve clinical trial efficiency through recruitment, artificial intelligence, and more. Listen to the full episode here: https://lnkd.in/eu_yBBp2 #startup #clinicalresearch #ai #healthcareinnovation

#ThrowbackThursday to last week, where Lindus Medical Director Luke Twelves presented data with Patrick Savoie and Maya Chaldecott from our trial with Accurx at #ATS2024! This trial examined the effectiveness of text message reminders in promoting inhaler adherence in patients with asthma and COPD, where together we recruited over 5,000 patients! We also discussed recruitment and engagement tactics such as EHR screening, collaborations with primary care, and more. Curious about how we conduct large-scale recruitment like such? DM us! #respiratory #inhaleradherence #patientengagement #recruitment